Long-Term Liabilities: The sum of all non-current liabilities.
Castle Biosciences, Inc. (CSTL) had Long-Term Liabilities of $37.63M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$83.68M |
|
$-14.52M |
|
$20.53M |
|
$63.15M |
|
$102.09M |
|
$-18.41M |
|
$3.99M |
|
$-14.41M |
|
$-14.41M |
|
$-14.52M |
|
$-14.52M |
|
$-14.52M |
|
$-14.52M |
|
$-18.41M |
|
$-14.93M |
|
29.89M |
|
29.89M |
|
$-0.49 |
|
$-0.49 |
|
| Balance Sheet Financials | |
$328.90M |
|
$100.93M |
|
$218.90M |
|
$547.80M |
|
$48.76M |
|
$8.69M |
|
|
Long-Term Liabilities |
$37.63M |
$86.39M |
|
$461.42M |
|
$364.07M |
|
$461.42M |
|
30.30M |
|
| Cash Flow Statement Financials | |
$-22.13M |
|
$-25.80M |
|
$-5.03M |
|
$116.73M |
|
$63.76M |
|
$-52.97M |
|
$9.78M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.75 |
|
-- |
|
-- |
|
0.02 |
|
0.02 |
|
75.46% |
|
-22.00% |
|
-22.00% |
|
-- |
|
-17.22% |
|
-17.35% |
|
$-34.58M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
1.96 |
|
1.98 |
|
45.46 |
|
-3.15% |
|
-3.99% |
|
-2.65% |
|
-3.09% |
|
$15.23 |
|
$-1.16 |
|
$-0.74 |
|